Related Experiment Video
Updated: Jun 26, 2026
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
An immunological panacea for cancer-related cachexia
Jingyu Xue1, Tianyi Lu1, Kailin Yang2
1Department of Obstetrics and Gynecology, Development and Related Diseases of Women and Children Key Laboratory of Sichuan Province and State Key Laboratory of Biotherapy, West China Second University Hospital, Sichuan University, and Collaborative Innovation Center, Chengdu, PR China.
Trends in Cancer
|June 24, 2026
Summary
Cancer cachexia is a complex immune-driven wasting syndrome, not just malnutrition. New research reveals immune system
Area of Science:
- Immunometabolism
- Oncology
- Systems Biology
Background:
- Cancer cachexia contributes significantly to cancer-related mortality.
- It is now understood as a complex immunometabolic process rather than simple malnutrition.
Purpose of the Study:
- To review recent discoveries on the immune system's role in cancer cachexia.
- To explore the mechanisms driving tissue wasting and metabolic competition.
- To discuss advanced multiomics and AI in clinical stratification and therapeutic development.
Main Methods:
- Literature review synthesizing paradigm-shifting discoveries.
- Delineation of inflammatory cascades and neuro-immune circuits.
- Dissection of metabolic competition between tumor cells and host immunity.
Main Results:
- The immune system is identified as the central conductor of cancer cachexia.
- Inflammatory pathways, neuro-immune interactions, and cellular plasticity drive muscle and adipose tissue catabolism.
- Metabolic competition between tumor and host immune cells accelerates wasting.
Conclusions:
- Cancer cachexia is a multi-organ immunometabolic network.
- Advanced technologies like single-cell multiomics and AI are crucial for understanding and managing cachexia.
- Future therapies will focus on individualized, multi-node immunometabolic interventions.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...